Trial Details

COMPLETED
Basic Information
Clinical ID c4505
Identifier NCT00409617
Trial Title Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn's Disease
Interventions BIOLOGICAL: adalimumab|BIOLOGICAL: adalimumab
Participant Information
Sponsor Abbott
City Graz
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2006-12
Primary Completion Date 2008-07
Completion Date 2008-07